ANATARA LIFESCIENCES LTD Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary
For personal use only
Entity name
ANATARA LIFESCIENCES LTD
Date of this announcement
Monday December 13, 2021
The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
Total number of +securities to be issued/transferred
Total number of | |||
ASX +security | +securities to be | ||
code | Security description | issued/transferred | Issue date |
New class - code | Options expiring 14 November 2025 exercisable at | 1,800,000 | 09/12/2021 |
to be confirmed | $0.225 ea |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted | 1 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
ANATARA LIFESCIENCES LTD
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 | Registered number type | Registration number |
ABN | 41145239872 | |
1.3 | ASX issuer code | |
ANR |
- The announcement is New announcement
- Date of this announcement
13/12/2021
Notification of Issue, Conversion or Payment up of Unquoted | 2 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
For personal use only
2.1 The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted | 3 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B
For personal use only
New +securities issued under an +employee incentive scheme
ASX +security code | +Security description | |
New class - code to be confirmed | Options expiring 14 November 2025 exercisable at $0.225 | |
ea | ||
+Security type | ISIN code | |
Options |
Date the +securities the subject of this notification were issued
9/12/2021
Will all the +securities issued in this class rank equally in all respects from their issue date? Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes
Provide details of the KMP or +associates being issued +securities. | |||
Name of KMP | Name of registered holder | Number of +securities | |
900,000 | |||
David Brookes - Director | David Brookes | ||
450,000 | |||
Sue MacLeman - Director | Dalroar Pty Ltd as t'ee for MacLeman | ||
Investment Trust | 450,000 | ||
Jane Ryan - Director | Jane Ryan | ||
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?
Yes
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.
Approved by Shareholders at the Annual General Meeting held on 16 November 2021. https://anataralifesciences.com/investors/corporate-governance/
Options Details | ||
+Security currency | Exercise price | Expiry date |
AUD - Australian Dollar | AUD 0.22500000 | 14/11/2025 |
Notification of Issue, Conversion or Payment up of Unquoted | 4 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option
Other
Description | |
only | Options exercisable at $0.225 ea and expire 14 November 2025 |
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme | |
or a summary of the terms | |
https://anataralifesciences.com/investors/corporate-governance/ | |
Any other information the entity wishes to provide about the +securities the subject of this notification |
- David Brookes: 900,000 at $0.225 ea; vesting 450,000 16 November 2022 & 450,000 16 November 2023; expire 14 November 2025
- Dalroar Pty Ltd as t'ee for MacLeman Investment Trust (Sue MacLeman): 450,000 at $0.225 ea; vesting 225,000 16 November 2022 & 225,000 16 November 2023; expire 14 November 2025
- Jane Ryan: 450,000 at $0.225 ea; vesting 225,000 16 November 2022 & 225,000 16 November 2023; expire 14 November 2025
useIssue details
For personal
Number of +securities
1,800,000
Notification of Issue, Conversion or Payment up of Unquoted | 5 / 7 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Anatara Lifesciences Ltd. published this content on 13 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 December 2021 01:15:04 UTC.
